Navigation Links
Standard & Poor's Announces Changes to U.S. Indices
Date:11/11/2008

& Gas Exploration & Production Sub-Industry index.

Following is a summary of the changes:

S&P 500 INDEX - November 12, 2008

COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY

DELETED General Growth Financials Retail REITs

Properties

S&P 500 INDEX - November 14, 2008

COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY

ADDED Cephalon Health Care Biotechnology

S&P MIDCAP 400 INDEX - November 14, 2008

COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY

ADDED Mariner Energy Energy Oil & Gas

Exploration &

Production

DELETED Cephalon Health Care Biotechnology

Additions to and deletions from an S&P equity index do not in any way reflect an opinion on the investment merits of the companies concerned.

About Standard & Poor's Index Services

Standard & Poor's Index Services, the world's leading index provider, maintains a wide variety of investable and benchmark indices to meet an array of investor needs. Its family of indices includes the S&P 500, an index with $1.5 trillion invested and $4.85 trillion benchmarked, and the S&P Global 1200, a composite index comprised of seven regional and country headline indices. For more information, please visit http://www.standardandpoors.com/indices.

About Standard & Poor's

Standard & Poor's, a division of The McGraw-Hill Companies (NYSE:

SOURCE Standard & Poor's
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Osteotechs Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio
2. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
3. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
5. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
6. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
7. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
10. Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy
11. WuXi AppTec VP and GM Invited to Join the AAMI Standards Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...LLE, Gabon, December 2 , ...roblem and Heritage" , Coinciding with th...0 the,Gabonese Republic is hosting an internationa... safeguarding biological resources in Africa. The,...e leaders, ministers,scientific experts, private ...
(Date:12/2/2009)...DGE, Mass., Dec. 2 TechConnect Wor...nology development and product integration in clea...ecember 11th deadline for technology abstracts and...r, TechConnect World, in association with the Nano...Clean Technology and Sustainable Industries Organi...
(Date:12/2/2009)...ORE, Dec. 2 S*BIO Pte Ltd today an...inhibitor, SB1518, at The American Society of Hema...rleans. ,, Data will be presented on the clinic...of SB1518 detailing its safety, tolerability and p...dose levels ranging from 100 to 600 mg. These dose...
(Date:12/2/2009)...NG, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pha...SE: SCR ), a leading pharmaceutical company,spec...rketing of branded,generic and proprietary pharmac... drugs have been included in China,s National Drug...China,s Ministry of Human Resources and Social,Sec...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
... have used the world,s thinnest material to create...nd ten atoms wide. , Reporting their peer-reviewe...nce, Dr Kostya Novoselov and Professor Andre Geim ...iversity of Manchester show that graphene can be c...l transistors having a size not much larger than t...
... April 17 Immucor, Inc.,(Nasdaq: BLUD ), a globa...,systems to the blood transfusion industry, announ...e against CEO Gioacchino "Nino" De Chirico has,con...e tribunal in Milan rendered a guilty verdict in t...cash payment of euro 13,500 by Immucor,s,Italian s...
... 17 National Transitions of Care,Coalition (NTOCC... of,recently developed tools for helping healthcar... inherent in transitioning patients from one,level...nation of several,months of collaboration between ...06 to address challenges associated with transitio...
Other Biology Technology:Graphene used to create world's smallest transistor 2Immucor CEO's Italian Trial Moves Toward Second Phase 2Immucor CEO's Italian Trial Moves Toward Second Phase 3Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 2Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 3Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 4Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 5
(Date:12/2/2009)... HOBOKEN, NJ According to the National Institute...diagnosed with diabetes already have some stage of...ge to the retina caused by leaky blood vessels, is...s and is one of the most feared diabetic complicat...ho,ve had diabetes for 10 years or more will exper...
(Date:12/1/2009)...Alzheimer,s disease, nerve cell degeneration plays...tions may possibly be derived from steering the ge...s have been published in the current issue of the ... a few years ago, neurogenesis the process of ner...le in the adult brain. The textbooks asserted that...
(Date:12/1/2009)...ntists, one from the United States, the other from...eader of his wolf pack, on remote Ellesmere Island...to finally find out what these "North Pole wolves"... harshest areas of the world., "We first encount...ech, a renowned U.S. Geological Survey (USGS) wolf...
Breaking Biology News(10 mins):Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3New source discovered for the generation of nerve cells in the brain 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 1While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 2While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 3New Website www loseadresssize com Launches 53709 1New Website www loseadresssize com Launches 53709 2
... Davis researcher known for her honey bee line "Ne...r Old World counterparts to enhance their positive...ry hygienic and very productive, and hopefully wil...," said UC Davis bee breeder-geneticist Susan Cobe...nica ) is a subspecies of the Western honey bee. T...
...From stiff plastic limbs and metal rods to complex...he crash test dummies of yesteryear are evolving a... Medicine are among those bringing them to life. ...epresent live humans with precision and detail not...ll contain detailed representation of the bones an...
...Colorado at Boulder study showing that American to...ir chances of parasitic infections known to cause ... benefits of biodiversity on emerging wildlife dis...d tadpoles were raised in tanks with the parasitic... tadpole limb regions and disrupt normal leg devel...
Other Biology News:Building a better bee 2Wake Forest plays integral role in effort to revolutionize vehicle safety 2Wake Forest plays integral role in effort to revolutionize vehicle safety 3New CU-Boulder study shows diversity decreases chances of parasitic disease 2New CU-Boulder study shows diversity decreases chances of parasitic disease 3
Recipient Needle, 1.0 mm, Spare part for ATA100 from CHEMICON
Mouse Anti-Mouse IgD Chain C Monoclonal Antibody, Unconjugated, Clone AMS 9.1 from Santa Cruz Biotechnology, Inc.
Chicken IgG ELISA Kit from Bethyl Laboratories
Ph.D.-C7C Disulfide Constrained Peptide Library Kit from New England Biolabs
Biology Products: